News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
Sarepta’s New Facility to Open in Early 2017, Plans to Hire 45 New Staffers
November 4, 2016
·
2 min read
FDA
This Is Why Woodcock OKed Sarepta’s DMD Drug
November 4, 2016
·
3 min read
Genetown
Humana to Cover Sarepta’s Controversial DMD Drug But There’s a Catch
October 27, 2016
·
2 min read
FDA
Sarepta Gets No Love From the FDA’s New Drugs Director
October 20, 2016
·
3 min read
BioCapital
SunTrust Managing Director Goes Over Sarepta’ Story
October 18, 2016
·
1 min read
Policy
PTC Therapeutics Wants a Slice of Sarepta’s DMD Pie, Says Rejected Drug May Help Some Patients
October 7, 2016
·
1 min read
Business
Sarepta Goes for a New DMD Combo With New $562 Million+ Deal With Summit Therapeutics
October 4, 2016
·
2 min read
Policy
After Sarepta’s Win, BioMarin Wants a Piece of the Action Too
September 23, 2016
·
1 min read
Drug Development
Saga Continues for Sarepta as FDA Head Calls for Retraction of ‘Misleading’ 2013 Study
September 23, 2016
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
November 26, 2025
·
12 min read
Press Releases
Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics
November 24, 2025
·
4 min read
Press Releases
Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1
November 24, 2025
·
4 min read
Press Releases
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
November 17, 2025
·
3 min read
Press Releases
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
November 17, 2025
·
10 min read
Press Releases
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
November 3, 2025
·
19 min read
Press Releases
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
October 28, 2025
·
1 min read
Press Releases
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress
October 6, 2025
·
16 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 30, 2025
October 1, 2025
·
1 min read
Press Releases
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year
September 8, 2025
·
4 min read
